SCHEMBL6748555

SCHEMBL6748555

CO/C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2NC=O)ncn1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.40
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPK8 P45983 1/20 0.35
MAPK10 P53779 1/20 0.35
ALDH1A1 P00352 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
RAB9A P51151 1/20 0.32
KDM4E B2RXH2 1/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
HTT P42858 1/20 0.32
RECQL P46063 1/20 0.32
PTK2 Q05397 1/20 0.31
CCR2 P41597 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16561719 0.90 MEN1 (0.41) MEN1KMT2AMAPK8MAPK10ALDH1A1
SCHEMBL248231 0.88 MEN1 (0.36) MEN1KMT2AMAPK8MAPK10ALDH1A1
SCHEMBL10431041 0.87 RAB9A (0.36) MEN1KMT2AMAPK8MAPK10ALDH1A1
SCHEMBL6744761 0.87 RAB9A (0.36) MEN1KMT2AMAPK8MAPK10ALDH1A1
SCHEMBL9121820 0.86 HTT (0.44) MEN1KMT2AMAPK8MAPK10ALDH1A1
SCHEMBL9121807 0.86 HTT (0.44) MEN1KMT2AMAPK8MAPK10ALDH1A1
SCHEMBL6448582 0.85 SMN1; SMN2 (0.42) TSHRMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL9125875 0.85 KMT2A (0.38) TSHRMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL8958973 0.85 MAPK8 (0.39) MEN1KMT2AMAPK8SMN1; SMN2KDM4E
SCHEMBL203515 0.85 MAPK8 (0.39) MEN1KMT2AMAPK8SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6777412-B2 PYRIMIDIN-4-YLOXY)PHENYL)-3-METHOXYPROPENOATE DERIVATIVES SYNGENTA LIMITED (GB) 2004-08-17 US disclosed
US-20040092746-A1 Pyrimidinyloxyphenyl-3-alkoxypropenoate derivatives as pesticides CLOUGH JOHN MARTIN (GB) 2004-05-13 US disclosed
US-6613773-B2 Pyrimidinyloxyphenyl-3-alkoxypropenoates derivatives SYNGENTA LIMITED (GB) 2003-09-02 US disclosed
US-20030060626-A1 Fungicides SYNGENTA LIMITED (GB) 2003-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092746-A1 Pyrimidinyloxyphenyl-3-alkoxypropenoate derivatives as pesticides DDT, SQOR, TH TSHR 946/4885MEN1 2186/4885KMT2A 491/4885
US-20030060626-A1 Fungicides CYP51A1, CYP1A1, CYP1A2 TSHR 2595/4885MEN1 686/4885KMT2A 352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.